← Back to Search

Travoprost for Open-Angle Glaucoma

Phase 2
Waitlist Available
Research Sponsored by Glaukos Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This study is evaluating whether the surgical procedure is safe for people with glaucoma or ocular hypertension.

Eligible Conditions
  • Open-Angle Glaucoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ocular Safety
Secondary outcome measures
Anterior Chamber Cells
Anterior Chamber Flare
Corneal Edema
+14 more

Side effects data

From 2019 Phase 3 trial • 565 Patients • NCT02914509
38%
Adverse Event
1%
Serious Adverse Event
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo Vehicle (PV)
OTX-TP (Sustained Release Travoprost) Intracanalicular Depot

Trial Design

1Treatment groups
Experimental Treatment
Group I: Implantation and ExchangeExperimental Treatment1 Intervention
Subjects will undergo implantation and exchange of a Travoprost Intraocular Implant through a small temporal clear corneal incision.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Travoprost
FDA approved

Find a Location

Who is running the clinical trial?

Glaukos CorporationLead Sponsor
65 Previous Clinical Trials
9,007 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of Exchange of Travoprost Intraocular Implant
2020. "Study of Exchange of Travoprost Intraocular Implant". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04615403.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top